- Home
- ANL vs MODD Comparison
ANL vs MODD Comparison
Compare ANL & MODD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ANL
- MODD
- Stock Information
- Founded
- ANL 2004
- MODD 1998
- Country
- ANL Cayman Islands
- MODD United States
- Employees
- ANL N/A
- MODD N/A
- Industry
- ANL
- MODD Industrial Specialties
- Sector
- ANL
- MODD Health Care
- Exchange
- ANL Nasdaq
- MODD Nasdaq
- Market Cap
- ANL 56.0M
- MODD 46.3M
- IPO Year
- ANL 2023
- MODD N/A
- Fundamental
- Price
- ANL $1.55
- MODD $0.69
- Analyst Decision
- ANL Hold
- MODD
- Analyst Count
- ANL 1
- MODD 0
- Target Price
- ANL N/A
- MODD N/A
- AVG Volume (30 Days)
- ANL 7.4K
- MODD 190.0K
- Earning Date
- ANL 08-08-2025
- MODD 08-13-2025
- Dividend Yield
- ANL N/A
- MODD N/A
- EPS Growth
- ANL N/A
- MODD N/A
- EPS
- ANL N/A
- MODD N/A
- Revenue
- ANL N/A
- MODD N/A
- Revenue This Year
- ANL N/A
- MODD N/A
- Revenue Next Year
- ANL N/A
- MODD N/A
- P/E Ratio
- ANL N/A
- MODD N/A
- Revenue Growth
- ANL N/A
- MODD N/A
- 52 Week Low
- ANL $1.10
- MODD $0.63
- 52 Week High
- ANL $4.10
- MODD $2.65
- Technical
- Relative Strength Index (RSI)
- ANL 47.53
- MODD 46.43
- Support Level
- ANL $1.50
- MODD $0.67
- Resistance Level
- ANL $1.60
- MODD $0.78
- Average True Range (ATR)
- ANL 0.07
- MODD 0.08
- MACD
- ANL 0.02
- MODD 0.01
- Stochastic Oscillator
- ANL 60.42
- MODD 54.88
About ANL Adlai Nortye Ltd.
Adlai Nortye Ltd is a clinical-stage biotechnology company focused on the discovery and development of cancer therapies for patients across the spectrum of tumor types. The company has a robust pipeline of drug candidates which includes buparlisib (AN2025), palupiprant (AN0025), and AN4005 in the clinical stage, and AN8025, AN9025, and AN1025 in the preclinical stage.
About MODD Modular Medical Inc.
Modular Medical Inc is a development stage medical device company which focuses on the design, development, and commercialization of insulin pumps using modernized technology to increase pump adoption in the diabetes marketplace. The company's products seek to serve both the type 1 and the rapidly growing, especially in terms of device adoption, type 2 diabetes markets.